Synergistic effects of combined platelet-activating factor receptor and epidermal growth factor receptor targeting in ovarian cancer cells
Yi Yu(Obstetrics and Gynecology Hospital of Fudan University), Congjian Xu(Shanghai Medical College of Fudan University)
Cited by 27
Related Papers
The expression of platelet-activating factor receptor modulates the cisplatin sensitivity of ovarian cancer cells: a novel target for combination therapy
|British Journal of Cancer|2014|27
Epidermal growth factor induces platelet-activating factor production through receptors transactivation and cytosolic phospholipase A2 in ovarian cancer cells
|Journal of Ovarian Research|2014|23
Transactivation of epidermal growth factor receptor through platelet-activating factor/receptor in ovarian cancer cells
|Journal of Experimental & Clinical Cancer Research|2014|22
An effective AKT inhibitor-PARP inhibitor combination therapy for recurrent ovarian cancer
|Cancer Chemotherapy and Pharmacology|2022|16
Transactivation of epidermal growth factor receptor through platelet-activating factor/receptor in ovarian cancer cells
|Journal of Experimental & Clinical Cancer Research|2014|3